Clinical Trial Update: NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NBP in Moyamoya disease patients at high risk of ischemic cerebrovascular events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cerebrovascular Disease
• Moyamoya Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• NBP

Snippet

Sponsor: yuanli Zhao | Conditions: Moyamoya Disease, Ischemic Cerebral Infarction | Phase 3 | Status: UNKNOWN